Biomarker research with prospective study designs for the early detection of cancer.
about
Circulating miR-132-3p as a Candidate Diagnostic Biomarker for Malignant MesotheliomaPeptideManager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species.Chromosomal alterations in exfoliated urothelial cells from bladder cancer cases and healthy men: a prospective screening studyCombination of MiR-103a-3p and mesothelin improves the biomarker performance of malignant mesothelioma diagnosis.Gold-plated magnetic polymers for highly specific enrichment and label-free detection of blood biomarkers under physiological conditions.EPMA position paper in cancer: current overview and future perspectives.Calretinin as a blood-based biomarker for mesotheliomaProspective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting.CANcer-specific Evaluation System (CANES): a high-accuracy platform, for preclinical single/multi-biomarker discovery.Assessment of potential predictors of calretinin and mesothelin to improve the diagnostic performance to detect malignant mesothelioma: results from a population-based cohort study.Soluble chemokine (C-X-C motif) ligand 16 (CXCL16) in urine as a novel biomarker candidate to identify high grade and muscle invasive urothelial carcinomas.Evaluation of a New Survivin ELISA and UBC® Rapid for the Detection of Bladder Cancer in Urine.Evaluation of disposable microfluidic chip design for automated and fast Immunoassays.Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancer.Biomarkers for Predicting Malignant Pleural Mesothelioma in a Mexican Population.Prediagnostic detection of mesothelioma by circulating calretinin and mesothelin - a case-control comparison nested into a prospective cohort of asbestos-exposed workers
P2860
Q29248725-1E5120CD-CA86-4793-8AD0-FDEB4679E49AQ34117442-BBB2663B-9E96-4248-B449-E703B0920E3DQ34587111-52C8DD33-9DF2-408F-88EE-4DEAA55279C8Q34627854-CDACB132-5648-4C8B-A2A1-82A950FC4A35Q35208790-80BB6AE3-A7A4-46F2-BF50-4CFDF30E0722Q35532215-862610B4-1AB2-45FD-8E3E-4C5238EB36B9Q36385172-D5803B43-A964-4DDE-BC93-6A24BFF00CF9Q37086048-1281E3A6-830A-4C2B-8CB5-E391FEA97FE2Q42378383-A4AE78E8-DCE0-411E-9E9B-D2AC12B1528DQ42650225-7B337225-B413-424F-9657-4470527DC074Q47093667-F6A4D3EE-42FC-4B50-A3D4-8E2340D2515CQ47561168-E57CA4F3-E20E-437F-A22E-DE40E73CAD88Q48361303-18B9B743-9A85-471B-8F4F-0774A06F0123Q55260399-F85A1C31-12A5-434D-B8BE-AD86E5D09690Q55647308-62C0A97C-4AD3-46FC-9B27-231413131268Q58698940-D332E535-EC7C-412F-AA07-2B02A8C06D5F
P2860
Biomarker research with prospective study designs for the early detection of cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Biomarker research with prospective study designs for the early detection of cancer.
@ast
Biomarker research with prospective study designs for the early detection of cancer.
@en
type
label
Biomarker research with prospective study designs for the early detection of cancer.
@ast
Biomarker research with prospective study designs for the early detection of cancer.
@en
prefLabel
Biomarker research with prospective study designs for the early detection of cancer.
@ast
Biomarker research with prospective study designs for the early detection of cancer.
@en
P2093
P50
P1476
Biomarker research with prospective study designs for the early detection of cancer.
@en
P2093
P304
P356
10.1016/J.BBAPAP.2013.12.007
P407
P577
2013-12-17T00:00:00Z